Qiagen (NYSE: QGEN)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-02 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.510 | ||||||
REV | 488.730M | 516.000M | 27.270M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Qiagen (NYSE: QGEN) through any online brokerage.
There are no as such competitors for Qiagen.
The latest price target for Qiagen (NYSE: QGEN) was reported by Wells Fargo on Tuesday, December 14, 2021. The analyst firm set a price target for 60.00 expecting QGEN to rise to within 12 months (a possible 20.80% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Qiagen (NYSE: QGEN) is $49.67 last updated August 5, 2022, 7:59 PM UTC.
There are no upcoming dividends for Qiagen.
Qiagen’s Q3 earnings are confirmed for Wednesday, November 2, 2022.
There is no upcoming split for Qiagen.
Qiagen is in the Healthcare sector and Diagnostics & Research industry. They are listed on the NYSE.